Jonathan Young

Insider Reports History

Entity
Individual
Location
C/O Akero Therapeutics, Inc., 170 Harbor Way 3 Rd Fl, South San Francisco, CA
Signature
/s/ Jonathan Young
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan Young:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Akero Therapeutics, Inc. Chief Operating Officer Common Stoek 263K $6.59M $25.03 Apr 1, 2024 Direct
Akero Therapeutics, Inc. Chief Operating Officer Common Stock 236K $6.19M $26.18 Sep 10, 2024 Direct
Akero Therapeutics, Inc. Chief Operating Officer Common Stock 20K $524K $26.18 Sep 13, 2024 By CM Irrevocable Trust
Akero Therapeutics, Inc. Chief Operating Officer Common Stock 20K $524K $26.18 Sep 13, 2024 By EA Irrevocable Trust
Akero Therapeutics, Inc. Chief Operating Officer Common Stock 20K $524K $26.18 Sep 13, 2024 By JL Irrevocable Trust
Akero Therapeutics, Inc. Chief Operating Officer Stock Option (Right to Buy) 0 Mar 1, 2024 Direct

Insider Reports Filed by Jonathan Young

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AKRO Akero Therapeutics, Inc. Sep 13, 2024 1 -$14.9K 4 Sep 13, 2024 Chief Operating Officer
AKRO Akero Therapeutics, Inc. Sep 3, 2024 2 -$134K 4 Sep 5, 2024 Chief Operating Officer
AKRO Akero Therapeutics, Inc. Aug 1, 2024 2 -$134K 4 Aug 2, 2024 Chief Operating Officer
AKRO Akero Therapeutics, Inc. Jun 28, 2024 2 -$95.8K 4 Jul 2, 2024 Chief Operating Officer
AKRO Akero Therapeutics, Inc. Jun 11, 2024 1 -$57K 4 Jun 13, 2024 Chief Operating Officer
AKRO Akero Therapeutics, Inc. Jun 3, 2024 1 -$96.4K 4 Jun 5, 2024 Chief Operating Officer
AKRO Akero Therapeutics, Inc. May 1, 2024 1 -$101K 4 May 2, 2024 Chief Operating Officer
AKRO Akero Therapeutics, Inc. Apr 1, 2024 2 -$122K 4 Apr 3, 2024 Chief Operating Officer
AKRO Akero Therapeutics, Inc. Mar 13, 2024 1 -$18.4K 4 Mar 15, 2024 Chief Operating Officer
AKRO Akero Therapeutics, Inc. Mar 1, 2024 2 $51.2K 4 Mar 5, 2024 Chief Operating Officer
AKRO Akero Therapeutics, Inc. Dec 27, 2023 3 -$95.5K 4 Dec 29, 2023 Chief Operating Officer
AKRO Akero Therapeutics, Inc. Dec 14, 2023 1 -$11.3K 4 Dec 18, 2023 Chief Operating Officer
AKRO Akero Therapeutics, Inc. Dec 8, 2023 2 $0 4 Dec 12, 2023 Chief Operating Officer
AKRO Akero Therapeutics, Inc. Nov 17, 2023 1 -$440K 4 Nov 21, 2023 Chief Operating Officer
AKRO Akero Therapeutics, Inc. Oct 2, 2023 3 -$14.7K 4 Oct 4, 2023 Chief Operating Officer
AKRO Akero Therapeutics, Inc. Sep 13, 2023 1 -$28.3K 4 Sep 25, 2023 Chief Operating Officer
AKRO Akero Therapeutics, Inc. Jun 13, 2023 1 -$29.7K 4 Jun 15, 2023 Chief Operating Officer
AKRO Akero Therapeutics, Inc. Mar 10, 2023 1 -$27.6K 4 Mar 14, 2023 Chief Operating Officer
AKRO Akero Therapeutics, Inc. Jan 3, 2023 3 -$474K 4 Jan 5, 2023 Chief Operating Officer
AKRO Akero Therapeutics, Inc. Dec 27, 2022 5 -$544K 4 Dec 28, 2022 Chief Operating Officer
AKRO Akero Therapeutics, Inc. Dec 16, 2022 1 $0 4 Dec 20, 2022 Chief Operating Officer
AKRO Akero Therapeutics, Inc. Dec 9, 2022 2 $0 4 Dec 13, 2022 Chief Operating Officer
AKRO Akero Therapeutics, Inc. Oct 25, 2022 3 -$479K 4 Oct 27, 2022 Chief Operating Officer
AKRO Akero Therapeutics, Inc. Sep 9, 2022 2 $0 4 Sep 13, 2022 Chief Operating Officer
AKRO Akero Therapeutics, Inc. Jan 7, 2022 3 $17.1K 4 Jan 11, 2022 Chief Operating Officer
AKRO Akero Therapeutics, Inc. Dec 8, 2021 1 $0 4 Dec 10, 2021 Chief Operating Officer
AKRO Akero Therapeutics, Inc. Nov 3, 2021 2 -$607K 4 Nov 5, 2021 Chief Operating Officer
AKRO Akero Therapeutics, Inc. Sep 1, 2021 1 -$301K 4 Sep 3, 2021 Chief Operating Officer
AKRO Akero Therapeutics, Inc. Jul 15, 2021 2 $5.54K 4 Jul 19, 2021 Chief Operating Officer
AKRO Akero Therapeutics, Inc. Jun 1, 2021 1 -$80.2K 4 Jun 2, 2021 Chief Operating Officer